UnitedHealth Group's pharmacy benefit manager, Optum Rx, said on Wednesday it would ease requirements to get insurance ...

Regeneron Pharmaceuticals Inc. closed 44.49% short of its 52-week high of $1,211.20, which the company reached on August 27th ...

The 2nd GLP-1-Based Therapeutics Summit returns to tackle the challenges in best-in-class GLP-1 development and indication ...

The investigators retrospectively evaluated 126 consecutive treatment-naïve nAMD patients (126 eyes) who received a loading ...

Vaccine Research Market Governments and private entities are heavily investing in vaccine research and development.US, NY, UNITED STA ...

OHSU's pioneering research, clinical trials led to better testing, approval for CTX disease Eric Stewart has a rare disease ...

Dupilumab vs placebo was linked to improved health-related quality of life and respiratory symptoms in patients with COPD and T2 inflammation.

February saw a flurry of significant hires in the agency world, with several key players making strategic appointments to bolster their leadership teams. We’ve also included consultancy and investor ...

DelveInsight's Molecular Glues Market Insights report includes a comprehensive understanding of current treatment practices, ...

Generali Asset Management SPA SGR has purchased 11,358 shares of Regeneron Pharmaceuticals, valued at approximately $8.1 ...